response

Androgen receptor antagonists compromise T cell response against prostate …
Surgical and medical androgen deprivation therapy (ADT) is a cornerstone for prostate cancer treatment, but relapse usually occurs. We herein show that orchiectomy synergizes with immunotherapy, whereas the more widely used treatment of medical ADT ... [...]
5
Like
Save
Common prostate cancer treatments suppress immune response and may promote relapse
Prostate cancer patients and their doctors may want to think twice about the best timing for chemotherapy or radiation therapy in conjunction with a common nonsurgical treatment, based on international research findings led by UT Southwestern Medical ... [...]
4
Like
Save
Response to Anti-TNF Linked to CV Risk in RA
Tumor necrosis factor (TNF) inhibitor treatment of rheumatoid arthritis (RA) that successfully reduces RA disease activity also appears to improve cardiovascular (CV) risk in this population. Compared with European League Against Rheumatism (EULAR) ... [...]
6
Like
Save
Sexual Intimacy and the Male Response After a Breast Cancer Diagnosis
The article said, “Many women find that breast cancer diagnosis and treatment seriously disrupt their sexual lives. First there are the most obvious issues—the physical changes, exhaustion, nausea and pain from treatment, self-image, empty energy ... [...]
6
Like
Save
Single Dose of Trastuzumab Kick Starts Immune Response in Certain Breast Cancers
“Our study showed, for the first time, that the immune-cell–activating properties of trastuzumab are likely related to the subtypes of breast cancer,” Varadan said. “Knowing this can inform future trials studying the usefulness of adding immunotherapy ... [...]
1
Like
Save
Antibodies Predict RA Response to Orencia
Note that this European registry study of patients with rheumatoid arthritis found that those with rheumatoid factor or anti-citrullinated peptide antibodies were more likely to continue treatment with abatacept. Be aware that lack of drug ... [...]
4
Like
Save
Nitroglycerin can boost body's natural immune response to cancer
The discovery builds on the Queen's team's 2009 findings related to the role of nitric oxide in suppressing tumour growth in prostate cancer. The researchers conducted the first-ever clinical trial using low doses of nitroglycerin to treat prostate cancer. [...]
4
Like
Save